Fiera Capital Corp
Source: SEC Form 13F · as of Mar 2026Fiera Capital Corp holds 14 biotech & pharma companies tracked by BioSniper, totaling $577.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$577.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INSMINSMED Inc | 1,021,970 | $167.1M |
| ARGXARGENX SE | 217,198 | $158.6M |
| TERNTerns Pharmaceuticals, Inc. | 711,326 | $37.5M |
| IMCRImmunocore Holdings plc | 1,080,099 | $32.6M |
| LGNDLigand Pharmaceuticals Incorporated | 135,312 | $27.0M |
| TVTXTravere Therapeutics, Inc. | 900,868 | $26.8M |
| GILDGILEAD SCIENCES, INC. | 187,420 | $26.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 78,822 | $26.1M |
| BBIOBridgeBio Pharma, Inc. | 322,690 | $24.0M |
| COGTCogent Biosciences, Inc. | 558,252 | $21.5M |
| QUREuniQure N.V. | 816,893 | $13.4M |
| ONCBeOne Medicines Ltd. | 33,782 | $10.0M |
| BHVNBiohaven Ltd. | 774,168 | $6.5M |
| NBPNovaBridge Biosciences | 315,681 | $777K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.